Novo Holdings Aligos Therapeutics, Inc. (ALGS) insider trading activity
Novo Holdings is > 10% Shareholder of Aligos Therapeutics, Inc.. Currently has a direct ownership of 2.61 Million shares of ALGS, which is worth approximately $1.54 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 200,000 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $3,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.61M
0%
3M change
0%
12M change
Total Value Held
$1.54 Million
Novo Holdings Transaction History
Also insider at
NH
Novo Holdings
> 10% Shareholder
Hellerup, G7